Excited to share first results of unedited CD5 CAR T in r/r T-cell lymphoma from a trial led by @HillLaQuisa and R.Rouce @CAGTHouston Infusions were safe and responses durable, with 2 pts still in CR 5+ years later. Multicenter Phase 2 later this year. https://t.co/NIzb2biIuy
@sghmd@BipinSavani Love @BipinSavani! He was a huge inspiration for me and many of my co-residents who ended up in heme/SCT!!Congratulations to you and your daughter; how lucky was she to be mentored by the amazing @sghmd; another BMT legend!
@sghmd@umn_dom Thank you all for the invite to come out!! It was truly and honor, and awesome to finally meet everyone face to face! Look forward to continued collaboration in the future!! And with the right gear the โ๏ธ wasnโt so bad ๐ฅถ๐ฅถ๐ฅถโค๏ธโค๏ธโค๏ธ
Based on these studies, we started a Phase I clinical trial (NCT03690011) in patients with r/r T-ALL and T-cell lymphoma led by @HillLaQuisa@CAGTHouston Very encouraging responses already, stay tuned for more updates 6/ https://t.co/NecWuEikYv
1. Build your Memory Log
Open a document. Title it โMemory Log.โ
Add one thing you want to remember from today.
โข A story
โข A moment
โข A conversation
Anything.
Doing this will inspire you to create more memories tomorrow.
Over time, itโll also become a cherished gift.
The #IOYIF21 1st place winner in the PhD Postdoc category is Dr. Mary Kathryn McKenna for her work using banana lectin-powered T-cells to augment targeted therapies in solid tumors. Congratulations, Dr. McKenna! @bcmhouston@CAGTHouston